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    The efficacy alld problems of the surgery and adjuvant therapy of 136 patients with renal cell
carcinoma who were treated at our hospitai between 1953 and 1980 were reviewed． The 5－year
survival rate was 45．OC／． for all the patients， and 72．89／，， 52．20／．， 84．60／． and OO／． for ’the patients with
stages 1， 2， 3 and 4 cancer， respectively， the survival rate for patients with cancer at an advanced
stage being poor．
    Clinical results of radiotherapy and combination theral y with four chemotherapeutic agents，’
cyclophosphamide， vincristine， methotrexate and actinomycin D used as adjuvant therapy for neph－
rectomy were investigated． For the patients who had stage 2 or 3 cancer， the survival rate was higher
with radiotherapy， and for patients with stage 1， 2 or 3 cancer， the survival rates were improved with
chemotherapy． Of the 46 patients who had stage 2 or 8 cancer， the 5－year survival rate for the 22
patients who received radiother4py as adjuvant therapy was 62．10／．， which was superior to the 5－year
survival rate （50．60／．） for the other 24 patients who did not receive radiotherapy． On the other hand，
of the 87 patients who had stage 1， 2 or 3 cancer， the 5－year survival rate for the 27 patients who re－
ceived chemotherapy as adjuvant therapy was 81．1？／o and that for the other 60 patients who did not
receive 4djuyant therapy was 63．10／．．
    The 5－year survival rate of 72．70／． obtained for the 43 patients who had stage 1 cancer was not
good． However， postoperative chemotherapy after nephrectomy by the no－touch technique and
preoperatiye transcathetgr renal 4rterial embolization seemed to be effective for improving survival
rate．
    Tu皿or invasion into the renal vein or inferior vena cava was fbund in 18 patients． Four of the
6 patients who received radical operation survived 2 years and 6 months to 11 years ．and 5 months
postoperatively． Thus， prolonged survival could be obtained even in cases showing tumor invasion
into the inferior vena cava if there was no distant metastasis and if tumor thrombus could be resected．
    Of the 34 patients who had distant metastasis at initial examination， the survival period for the
18 patients who had undergone nephrectomy was longer than that for the 16 patients who had not
been operated on． Five of the 23 patients who deveiQped postoperative recurrence survived for 5
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years and 1 month to l l years and 5 months after the operation， These findings suggest that ag－
gressive therapy is effective for renal cell carcinoma accompanied by metastasis．



























 以上の分類により136例のstageをみると， stage l
｝ま43｛列， 31．6％，stage 2 ｝ま36｛列， 26．5％， stage 3 1ま
21例，15．4％（stage 3A 10例， stage 3B 8例， stage

















｝ま83．1％， 55．8％， 52．2％， stage 3 ｝ま51．2％， 34．6
％，34．6％，stage 4は47．2％，16．3％，0％で，
stageがすすむほど生存率が不良になる傾向がみられ，
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cyclophosphamide 100 mg， vincristine 1 mg， metho－
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恥 氏名  年齢 性別 患側stage術後の転移発生 転帰（生存期間）
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